CompletedNot Applicable

PROTECT-ASUC: Covid-19 Pandemic Response Of assessmenT, EndosCopy and Treatment in Acute Severe Ulcerative Colitis

United Kingdom10 participantsStarted 2020-05-20

Plain-language summary

Whether the perceived changes in management of Acute Severe Ulcerative Colitis during the COVID pandemic are widespread, and whether they have any impact on patient outcomes

Who can participate

Age range16 Years – 100 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients aged 16 -100 inclusive * Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period Exclusion Criteria: * Patients aged 16 -100 inclusive * Acute Severe Ulcerative Colitis based on Modified Truelove and Witts Severity Index managed during the study period * Admission for elective colectomy * Pouch or stoma

What they're measuring

Primary outcome measure: The need for in-hospital colectomy or rescue therapy

Timeframe: 3 months

Trial details

NCT IDNCT04411784

SponsorHull University Teaching Hospitals NHS Trust

Sponsor typeOTHER_GOV

Study typeOBSERVATIONAL

Primary completion2020-08-31

View on ClinicalTrials.gov More Inflammatory Bowel Diseases trials